Publication | Open Access
Effect of erlotinib plus bevacizumab on brain metastases in patients with non-small cell lung cancer
22
Citations
13
References
2018
Year
E+B can be used as first-line therapy for BM, even in patients with BM-related neurologic symptoms and multiple BMs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1